CA2563871A1 - Game - Google Patents
Game Download PDFInfo
- Publication number
- CA2563871A1 CA2563871A1 CA002563871A CA2563871A CA2563871A1 CA 2563871 A1 CA2563871 A1 CA 2563871A1 CA 002563871 A CA002563871 A CA 002563871A CA 2563871 A CA2563871 A CA 2563871A CA 2563871 A1 CA2563871 A1 CA 2563871A1
- Authority
- CA
- Canada
- Prior art keywords
- game
- user
- opponents
- condition
- questions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000012545 processing Methods 0.000 claims description 45
- 201000010099 disease Diseases 0.000 claims description 41
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 41
- 230000000694 effects Effects 0.000 claims description 40
- 238000000034 method Methods 0.000 claims description 37
- 230000004044 response Effects 0.000 claims description 20
- 238000004590 computer program Methods 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 36
- 239000000446 fuel Substances 0.000 description 29
- 210000004027 cell Anatomy 0.000 description 23
- 230000036541 health Effects 0.000 description 23
- 206010020772 Hypertension Diseases 0.000 description 22
- 230000036772 blood pressure Effects 0.000 description 22
- 230000006378 damage Effects 0.000 description 22
- 210000004369 blood Anatomy 0.000 description 21
- 239000008280 blood Substances 0.000 description 21
- 208000008589 Obesity Diseases 0.000 description 15
- 235000020824 obesity Nutrition 0.000 description 15
- 235000012000 cholesterol Nutrition 0.000 description 13
- 230000008569 process Effects 0.000 description 13
- 239000000523 sample Substances 0.000 description 13
- 208000029078 coronary artery disease Diseases 0.000 description 12
- 210000004204 blood vessel Anatomy 0.000 description 11
- 210000004556 brain Anatomy 0.000 description 11
- 210000000265 leukocyte Anatomy 0.000 description 10
- 102000051325 Glucagon Human genes 0.000 description 9
- 108060003199 Glucagon Proteins 0.000 description 9
- 239000003925 fat Substances 0.000 description 9
- 235000019197 fats Nutrition 0.000 description 9
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 9
- 229960004666 glucagon Drugs 0.000 description 9
- 229940088597 hormone Drugs 0.000 description 9
- 239000005556 hormone Substances 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 8
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 7
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 7
- 210000003128 head Anatomy 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 230000037081 physical activity Effects 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 5
- 229910002092 carbon dioxide Inorganic materials 0.000 description 5
- 238000004891 communication Methods 0.000 description 5
- 210000003743 erythrocyte Anatomy 0.000 description 5
- 210000001105 femoral artery Anatomy 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 230000033001 locomotion Effects 0.000 description 5
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 108010010234 HDL Lipoproteins Proteins 0.000 description 4
- 102000015779 HDL Lipoproteins Human genes 0.000 description 4
- 102000004877 Insulin Human genes 0.000 description 4
- 108090001061 Insulin Proteins 0.000 description 4
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 4
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 4
- 229940125396 insulin Drugs 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 230000037361 pathway Effects 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 229940076279 serotonin Drugs 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 229920002527 Glycogen Polymers 0.000 description 3
- 108010007622 LDL Lipoproteins Proteins 0.000 description 3
- 102000007330 LDL Lipoproteins Human genes 0.000 description 3
- 208000001132 Osteoporosis Diseases 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 238000004422 calculation algorithm Methods 0.000 description 3
- 230000001627 detrimental effect Effects 0.000 description 3
- 235000005686 eating Nutrition 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 229940096919 glycogen Drugs 0.000 description 3
- 210000000987 immune system Anatomy 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 230000008092 positive effect Effects 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 235000021003 saturated fats Nutrition 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000035488 systolic blood pressure Effects 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- 239000003981 vehicle Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- UPLPHRJJTCUQAY-WIRWPRASSA-N 2,3-thioepoxy madol Chemical compound C([C@@H]1CC2)[C@@H]3S[C@@H]3C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@](C)(O)[C@@]2(C)CC1 UPLPHRJJTCUQAY-WIRWPRASSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 2
- 208000003443 Unconsciousness Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 210000000709 aorta Anatomy 0.000 description 2
- 238000013473 artificial intelligence Methods 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000008499 blood brain barrier function Effects 0.000 description 2
- 210000001218 blood-brain barrier Anatomy 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 210000002837 heart atrium Anatomy 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 210000002767 hepatic artery Anatomy 0.000 description 2
- 229960000890 hydrocortisone Drugs 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000003032 molecular docking Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 210000005241 right ventricle Anatomy 0.000 description 2
- 235000015598 salt intake Nutrition 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000010891 toxic waste Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 235000021081 unsaturated fats Nutrition 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000252506 Characiformes Species 0.000 description 1
- 241001137251 Corvidae Species 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- 206010013496 Disturbance in attention Diseases 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 238000008214 LDL Cholesterol Methods 0.000 description 1
- 206010024825 Loose associations Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 210000002376 aorta thoracic Anatomy 0.000 description 1
- 210000002565 arteriole Anatomy 0.000 description 1
- 230000000386 athletic effect Effects 0.000 description 1
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000010256 bone deposition Effects 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 230000008131 children development Effects 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 231100000040 eye damage Toxicity 0.000 description 1
- 235000013410 fast food Nutrition 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 235000021384 green leafy vegetables Nutrition 0.000 description 1
- 210000004884 grey matter Anatomy 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 235000020981 healthy eating habits Nutrition 0.000 description 1
- 201000010235 heart cancer Diseases 0.000 description 1
- 208000024348 heart neoplasm Diseases 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 210000003111 iliac vein Anatomy 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000005246 left atrium Anatomy 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 108010022197 lipoprotein cholesterol Proteins 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000003924 mental process Effects 0.000 description 1
- SYHGEUNFJIGTRX-UHFFFAOYSA-N methylenedioxypyrovalerone Chemical compound C=1C=C2OCOC2=CC=1C(=O)C(CCC)N1CCCC1 SYHGEUNFJIGTRX-UHFFFAOYSA-N 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 210000001328 optic nerve Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 235000015108 pies Nutrition 0.000 description 1
- 235000017924 poor diet Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 210000001147 pulmonary artery Anatomy 0.000 description 1
- 210000003492 pulmonary vein Anatomy 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000005245 right atrium Anatomy 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 208000011818 severe chest pain Diseases 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 210000000225 synapse Anatomy 0.000 description 1
- 230000001839 systemic circulation Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000001631 vena cava inferior Anatomy 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
- G09B—EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
- G09B23/00—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes
- G09B23/28—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine
- G09B23/30—Anatomical models
-
- A—HUMAN NECESSITIES
- A63—SPORTS; GAMES; AMUSEMENTS
- A63F—CARD, BOARD, OR ROULETTE GAMES; INDOOR GAMES USING SMALL MOVING PLAYING BODIES; VIDEO GAMES; GAMES NOT OTHERWISE PROVIDED FOR
- A63F13/00—Video games, i.e. games using an electronically generated display having two or more dimensions
- A63F13/50—Controlling the output signals based on the game progress
-
- G—PHYSICS
- G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
- G09B—EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
- G09B23/00—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes
- G09B23/28—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine
-
- A—HUMAN NECESSITIES
- A63—SPORTS; GAMES; AMUSEMENTS
- A63F—CARD, BOARD, OR ROULETTE GAMES; INDOOR GAMES USING SMALL MOVING PLAYING BODIES; VIDEO GAMES; GAMES NOT OTHERWISE PROVIDED FOR
- A63F2300/00—Features of games using an electronically generated display having two or more dimensions, e.g. on a television screen, showing representations related to the game
- A63F2300/80—Features of games using an electronically generated display having two or more dimensions, e.g. on a television screen, showing representations related to the game specially adapted for executing a specific type of game
- A63F2300/8094—Unusual game types, e.g. virtual cooking
Landscapes
- Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Multimedia (AREA)
- Medical Informatics (AREA)
- Mathematical Analysis (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Algebra (AREA)
- Computational Mathematics (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Mathematical Optimization (AREA)
- Mathematical Physics (AREA)
- Pure & Applied Mathematics (AREA)
- Business, Economics & Management (AREA)
- Educational Administration (AREA)
- Educational Technology (AREA)
- Theoretical Computer Science (AREA)
- Electrically Operated Instructional Devices (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2003901956 | 2003-04-24 | ||
| AU2003901956A AU2003901956A0 (en) | 2003-04-24 | 2003-04-24 | Game |
| US46651103P | 2003-04-29 | 2003-04-29 | |
| US60/466,511 | 2003-04-29 | ||
| PCT/AU2004/000537 WO2004094015A1 (en) | 2003-04-24 | 2004-04-23 | Game |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2563871A1 true CA2563871A1 (en) | 2004-11-04 |
Family
ID=33311319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002563871A Abandoned CA2563871A1 (en) | 2003-04-24 | 2004-04-23 | Game |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1620188A4 (https=) |
| JP (1) | JP2006524068A (https=) |
| AU (1) | AU2004231279B2 (https=) |
| CA (1) | CA2563871A1 (https=) |
| NZ (1) | NZ543672A (https=) |
| WO (1) | WO2004094015A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012029034A1 (en) * | 2010-09-02 | 2012-03-08 | Koninklijke Philips Electronics N.V. | Intuitive presentation of ventilation effectiveness |
| WO2014050036A1 (ja) | 2012-09-27 | 2014-04-03 | グリー株式会社 | サーバ、サーバの制御方法、及びプログラム |
| JP7655577B2 (ja) * | 2023-07-14 | 2025-04-02 | 株式会社コナミアミューズメント | ゲームシステム、ゲーム制御方法およびプログラム |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5215309A (en) * | 1991-01-15 | 1993-06-01 | Joel Deborah L | Health game |
| US5228860A (en) * | 1992-04-30 | 1993-07-20 | Hale Steven A | AIDS: the epidemic board game |
| US5956501A (en) * | 1997-01-10 | 1999-09-21 | Health Hero Network, Inc. | Disease simulation system and method |
| US6210272B1 (en) * | 1997-12-22 | 2001-04-03 | Health Hero Network, Inc. | Multi-player interactive electronic game for health education |
| US5556100A (en) * | 1995-05-31 | 1996-09-17 | Baylor University | Game of the immune system |
| US5813863A (en) * | 1996-05-01 | 1998-09-29 | Sloane; Sharon R. | Interactive behavior modification system |
| JP2897986B1 (ja) * | 1998-06-29 | 1999-05-31 | コナミ株式会社 | ビデオゲーム装置、ビデオゲームの表示制御方法及びビデオゲームプログラムが記録された可読記録媒体 |
| JP4283397B2 (ja) * | 1999-08-26 | 2009-06-24 | 任天堂株式会社 | 通信ゲームシステム、ゲーム機及び情報記憶媒体 |
| US6616532B2 (en) * | 2000-11-13 | 2003-09-09 | John M. Albrecht | Electronic game enhancement systems and methods |
-
2004
- 2004-04-23 NZ NZ543672A patent/NZ543672A/en not_active IP Right Cessation
- 2004-04-23 CA CA002563871A patent/CA2563871A1/en not_active Abandoned
- 2004-04-23 WO PCT/AU2004/000537 patent/WO2004094015A1/en not_active Ceased
- 2004-04-23 JP JP2006504021A patent/JP2006524068A/ja active Pending
- 2004-04-23 EP EP04729015A patent/EP1620188A4/en not_active Ceased
- 2004-04-23 AU AU2004231279A patent/AU2004231279B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004094015A1 (en) | 2004-11-04 |
| NZ543672A (https=) | 2007-07-27 |
| EP1620188A1 (en) | 2006-02-01 |
| EP1620188A4 (en) | 2006-07-26 |
| AU2004231279A1 (en) | 2004-11-04 |
| AU2004231279B2 (en) | 2010-04-01 |
| JP2006524068A (ja) | 2006-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8092226B2 (en) | Game for educating users regarding medical conditions | |
| Holmes | The Iliad's Economy of Pain | |
| Harrer | Games and bereavement: How video games represent attachment, loss, and grief | |
| AU2020324695A1 (en) | Exercise management system, server system, terminal device, and exercise management method | |
| CA3149533A1 (en) | Exercise management system, server system, terminal device, and exercise management method | |
| Tindle | Up: how positive outlook can transform our health and aging | |
| Caldwell et al. | The intersection of video games and patient empowerment: case study of a real world application | |
| Noakes | Challenging beliefs: Memoirs of a career | |
| AU2004231279B2 (en) | Game | |
| Wang et al. | Evaluation of the game exermon–A strength exergame inspired by pokémon go | |
| Gallwey et al. | The inner game of stress: Outsmart life's challenges and fulfill your potential | |
| Lauer-Schmaltz et al. | “Beat me if I can!”–A Case Study on Human Digital Twin-based Opponents in Rehabilitation Gaming | |
| Kayali et al. | A participatory game design approach for children after cancer treatment | |
| McKellar | Surgical limits: the life of Gordon Murray | |
| Cheney et al. | Heart: An American Medical Odyssey | |
| Fox | Wake Up! You're Alive | |
| Plechawska-Wójcik et al. | A serious game raising awareness and experience of depression | |
| Roizen et al. | This Is Your Do-Over: The 7 Secrets to Losing Weight, Living Longer, and Getting a Second Chance at the Life You Want | |
| Knaus | Persuasive technologies and applications in health and fitness | |
| Iedwab et al. | Martial arts: Mind & body | |
| Graham | Comfort Quest: Designing a Game to Help People with Anxiety Disorder Through Wellness Strategies and Comfort | |
| Ranta | Digital games and physical rehabilitation of low back pain: A comparative analysis of | |
| Forencich | Exuberant animal: The power of health, play and joyful movement | |
| Alvarado | Exergames for youth with cerebral palsy: Designing for Gameplay and Social Accessibility | |
| Brinkman | Database of Video Games and Their Therapeutic Properties |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |